Skip to content

Oral versus Intravenous Hydration to Prevent Contrast Induced Nephropathy

Oral versus Intravenous Hydration to Prevent Contrast Induced Nephropathy - Oral versus Intravenous Hydration to Prevent Contrast Induced Nephropathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37218
Enrollment
2200
Registered
2012-07-18
Start date
2012-08-29
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

contrast-induced nephropathy/ kidney damage after contrast administration

Interventions

Arm A: sodium chloride 1g/10kg of body weight /day per os on day -2 and -1 before contrast exposure. (maximum of 10 gram per day in case of obesitas) Arm B (standard procedure): Nacl 0.9% total 1000m

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult patients >18 years undergoing an elective procedure involving intravascular administration of iodinated contrast media and at high risk for the development of Contrast Induced Nephropathy (as defined by guideline criteria). High Risk (HR) eGFR= 2 risk factors: - Peripheral Arterial Disease - Heart Failure - Age >75 yrs - Anemia (Ht 150ml - Cardiological intervention eGFR

Exclusion criteria

Exclusion criteria: Age 25% change

Design outcomes

Primary

MeasureTime frame
The primary endpoint will be the ratio between the 48-72 hours creatinine levels and the baseline levels.

Secondary

MeasureTime frame
In addition, we will evaluate the incidence of contrast nephropathy in the groups Defined as a rise in serum creatinine of >=25% or >=44umol/L 48-72 hours after contrast administration. Finally, the incidence of adverse event will be evaluated. And patient satisfaction.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)